Familial renal oncocytoma is a rare inherited condition that causes one or more kidney tumors called oncocytomas. These growths are usually noncancerous, and many people with familial renal oncocytoma have no symptoms at first, so a scan done for another reason may find them. Many living with familial renal oncocytoma are recognized in adulthood, and the tendency to develop these tumors can be lifelong. Not everyone will have the same experience. Treatment often involves regular kidney imaging and, when needed, surgery or other kidney-sparing care, and death from the oncocytomas themselves is uncommon, although doctors also watch closely for early signs of familial renal oncocytoma and for the small chance of other kidney tumors in some families.
How many people live with Familial renal oncocytoma?
Worldwide and U.S. prevalence estimates for familial renal oncocytoma are not consistently reported by a single authoritative source, so there is no reliable published number for how many people live with it globally or in the United States. Rare disease references describe it as extremely rare and mainly reported in individual families rather than counted in large population studies (Orphanet, 2024).
Overview
Familial renal oncocytomaSymptoms
Familial renal oncocytoma often causes no early signs. Many people learn they have it after imaging for another reason. When signs do appear, they can include blood in the urine, side or back pain, or a kidney mass.
Outlook and prognosis
Many people with familial renal oncocytoma do well with regular kidney imaging and follow-up. These tumors are usually slow-growing and often noncancerous, but ongoing checks matter because new kidney tumors can develop over time.
Causes and risk factors
Familial renal oncocytoma is usually linked to an inherited genetic change, so a family history is the main risk factor. Lifestyle or environmental factors are not known primary causes, though smoking can raise overall kidney tumor risk.
Genetic influences
Genetics are very important in familial renal oncocytoma because it tends to run in families. In some people, inherited genetic changes raise the risk, but the exact gene change is not always found in every family.
Diagnosis
Familial renal oncocytoma is usually suspected from kidney scans and a family history of similar tumors. Diagnosis is confirmed by imaging, biopsy or surgery results, and sometimes genetic tests as part of the diagnosis of Familial renal oncocytoma.
Treatment and drugs
Familial renal oncocytoma is usually managed with regular kidney imaging to watch tumors over time, since many grow slowly. If a mass becomes large, painful, or unclear, surgery to remove part or all of the kidney may be recommended.
Symptoms
Many people with familial renal oncocytoma feel well for a long time, and the condition is often picked up during imaging done for another reason. It causes kidney growths called oncocytomas, which are usually noncancerous, and some people have more than one growth or have them in both kidneys. Features vary from person to person and can change over time. When signs do appear, they usually involve the kidneys or urine.
Many people with familial renal oncocytoma do not notice anything unusual, especially when the growths are small. It is often found by chance during an ultrasound, CT scan, or MRI done for another reason. This is why the early features of familial renal oncocytoma can be easy to miss.
Some people notice pink, red, or brown urine if a kidney growth bleeds into the urinary tract. This may happen once or come and go, but it still needs medical attention.
A dull ache or pressure in the side or lower back can happen when a growth stretches the kidney or nearby tissues. The feeling is often more of a persistent soreness than sharp pain.
Larger or multiple growths can cause a sense of heaviness, fullness, or a lump in the belly or side. Some may find that bending, twisting, or lying on one side feels less comfortable.
How people usually first notice Familial renal oncocytoma?
Many people first notice familial renal oncocytoma only after an imaging test, such as an ultrasound or CT scan, finds a kidney mass by chance while checking something else, because these tumors often cause no symptoms at first. When there are early warning signs, they may include blood in the urine, flank or lower back pain, or less often a feeling of fullness in the abdomen, but some people with familial renal oncocytoma never feel anything unusual. Because this condition can run in families, how familial renal oncocytoma is first noticed may also be through screening after a relative is diagnosed, rather than from symptoms alone.
Types of Familial renal oncocytoma
No distinct types of Familial renal oncocytoma are widely recognized.
Can I slow down the onset of symptoms?
No, at this time there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of familial renal oncocytoma, an inherited tendency to develop certain kidney tumors. Healthy habits like not smoking, staying active, managing blood pressure, and getting routine medical care are still important for overall kidney health, but they have not been shown to prevent this condition or clearly postpone symptoms. What can help is regular follow-up with a kidney specialist or genetics team, since scheduled kidney scans may find tumors early and guide treatment if needed, even though this does not stop the condition from starting.
What genetics can tell you about symptoms
Genetics can show whether a family has an inherited tendency to develop renal oncocytomas, and in some families it may help explain why tumors appear earlier, in both kidneys, or in greater numbers. But it usually cannot predict the exact symptoms someone will have, because many people with familial renal oncocytoma have no symptoms at all, while others may only notice problems if a tumor grows large enough to cause pain, blood in the urine, or a mass found on imaging. In other words, the genetic change helps predict risk and pattern more than day-to-day symptoms or how severe they will be.
Causes and risk factors
Familial renal oncocytoma usually happens because of an inherited gene change that runs in families and raises the chance of noncancerous kidney tumors. Having a parent, sibling, or child with familial renal oncocytoma is the strongest known risk factor. Age may affect when these tumors show up, but smoking, diet, and other exposures are not known to be the main cause. Genetic testing can sometimes clarify your personal risk. If you are trying to understand the risk factors for familial renal oncocytoma, family history matters most, and your doctor may suggest kidney scans over time.
What are the most common causes or risk factors?
The main cause of familial renal oncocytoma is an inherited tendency to develop this kind of kidney tumor, so the biggest risk factor is having close relatives with the same or similar kidney tumors. In some families, this is linked to an inherited gene change, especially in a rare condition called Birt-Hogg-Dubé syndrome, which can also cause skin bumps and small air-filled spaces in the lungs. These tumors are usually found in adulthood, so age can play a role, but common lifestyle risks like smoking or excess weight have not been clearly shown to be major causes of the familial form.
Environmental and biological risk factors
Familial renal oncocytoma does not have well-established environmental or non-genetic biological risk factors that clearly raise the chance of it occurring. In practice, experts do not have strong evidence that exposures, infections, diet, or common medical conditions cause this condition. Awareness of both biological and environmental influences helps you feel prepared, but for familial renal oncocytoma, those influences have not been clearly defined outside of inherited risk.
Genetic risk factors
Familial renal oncocytoma tends to show up in families because of inherited changes that raise the chance of certain kidney tumors, sometimes in both kidneys or in more than one spot. When people ask about the genetic risk factors for familial renal oncocytoma, the main one doctors look for is a harmful change in the FLCN gene, often linked with Birt-Hogg-Dubé syndrome. Carrying a genetic change doesn’t guarantee the condition will appear.
FLCN changes: Inherited harmful changes in the FLCN gene are the best-known genetic cause of familial renal oncocytoma. This gene helps control cell growth, and when it is altered, the risk of kidney tumors with oncocytic features can rise.
Birt-Hogg-Dubé syndrome: Familial renal oncocytoma often occurs as part of Birt-Hogg-Dubé syndrome, an inherited condition caused by FLCN changes. In these families, kidney growths can include oncocytomas as well as some related tumor types.
Autosomal dominant inheritance: This inherited risk is usually passed down in an autosomal dominant pattern, meaning each child of a parent with the gene change has a 1 in 2, or 50%, chance of inheriting it. That is why kidney tumors may appear in several relatives across more than one generation.
Family history: Having a parent, sibling, or child with familial renal oncocytoma or Birt-Hogg-Dubé syndrome raises the chance that the risk is inherited. This matters even if relatives have had different tumor types or few symptoms, because the same gene change can affect family members differently.
Lifestyle risk factors
Lifestyle habits do not cause familial renal oncocytoma, but they can still influence kidney health, symptoms, and the risk of complications over time. When people ask how lifestyle affects familial renal oncocytoma, the main issues are protecting overall kidney function and reducing added stress on the kidneys. Daily habits also matter if monitoring shows tumor growth or if treatment such as surgery becomes necessary.
Smoking does not cause the inherited condition, but it can damage blood vessels and reduce kidney reserve over time. In someone with familial renal oncocytoma, that may make it harder to tolerate tumors, surgery, or other kidney problems if they occur.
Poorly controlled blood pressure can strain the kidneys and speed loss of kidney function. For people with familial renal oncocytoma, keeping blood pressure in a healthy range may help preserve renal function during long-term surveillance or after partial kidney surgery.
Obesity and a diet high in salt or heavily processed foods can worsen hypertension and metabolic stress on the kidneys. In familial renal oncocytoma, these lifestyle risk factors may not drive the tumors themselves, but they can increase the chance of kidney-related complications and reduce overall renal resilience.
Repeated dehydration can temporarily lower kidney perfusion and add stress to kidney tissue. Staying well hydrated may help support kidney function, especially in people with familial renal oncocytoma who need ongoing imaging, follow-up, or treatment.
Risk prevention
For people with Familial renal oncocytoma, there is usually no proven way to prevent the condition itself because the main risk comes from an inherited gene change. Prevention is mainly about finding kidney tumors early, protecting kidney function, and lowering the chance of complications from treatment or other kidney stress. Some prevention is universal, others are tailored to people with specific risks.
If Familial renal oncocytoma runs in your family, genetic counseling can help clarify who may be at risk and who might benefit from testing. This can guide earlier kidney monitoring for relatives before problems develop.
Planned kidney scans are one of the most important ways to reduce harm from Familial renal oncocytoma. They can help spot growth changes before tumors cause pain, bleeding, or pressure on nearby kidney tissue.
Ongoing follow-up with a urologist or kidney specialist helps balance early treatment with avoiding unnecessary procedures. This matters because many living with Familial renal oncocytoma may develop more than one tumor over time.
Staying well hydrated, keeping blood pressure in a healthy range, and avoiding smoking can help protect overall kidney health. Alongside medical care, everyday habits also matter.
Can you prevent Familial renal oncocytoma?
No, you usually cannot prevent familial renal oncocytoma because it is an inherited condition that runs in families. Healthy habits like not smoking, staying at a healthy weight, and keeping blood pressure under control are good for overall kidney health, but they have not been proven to stop this inherited condition from happening. For many people living with familial renal oncocytoma, the most helpful step is regular medical follow-up so any kidney growths can be found early.
Transmission
Familial renal oncocytoma is not infectious, so it cannot be caught from someone through touch, coughing, sex, blood, food, or shared spaces. What can run in families is an inherited tendency to develop these kidney tumors.
When doctors explain how Familial renal oncocytoma is inherited, they usually mean a parent can pass down the related gene change in an autosomal dominant pattern, which means each child has a 1 in 2 chance of inheriting that risk. Even within the same family, people with Familial renal oncocytoma may not all be affected in the same way, and some families are only recognized after more than one relative develops kidney tumors.
When to test your genes
Consider genetic testing if you or close relatives have had renal oncocytomas, especially at a younger age or with tumors in both kidneys or multiple kidney tumors. Testing can clarify whether an inherited syndrome such as Birt-Hogg-Dube is involved and help guide kidney screening for you and your family.
Diagnosis
Familial renal oncocytoma is often suspected when kidney tumors are found on imaging, especially if more than one tumor is present or there is a family history of similar growths. Many living with familial renal oncocytoma have few or no symptoms, so the diagnosis may begin after a scan done for another reason or when blood in the urine, side pain, or a kidney mass needs a closer look. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of familial renal oncocytoma usually combines imaging findings, pathology, and family history, and genetic testing may be offered in some cases.
Doctors ask about symptoms, past kidney problems, and whether close relatives have had kidney tumors or related syndromes. A detailed family and health history can help show whether the pattern looks inherited rather than a single isolated tumor.
An exam cannot confirm this condition on its own, but it helps check for signs that could point to another cause or a broader inherited syndrome. Doctors also look for clues that may affect which tests are most useful next.
Ultrasound, CT scans, and MRI scans are used to find kidney masses and show their size, number, and location. In familial renal oncocytoma, imaging can suggest a slow-growing tumor, but scans alone usually cannot prove the exact tumor type.
Urine testing may look for blood or other changes, and blood tests check kidney function. These results do not diagnose familial renal oncocytoma directly, but they help rule out other conditions and guide treatment planning.
How is Familial renal oncocytoma diagnosed?
Familial renal oncocytoma is usually suspected when kidney scans such as an ultrasound, CT scan, or MRI show one or more kidney growths, especially if several relatives have had similar tumors. Because scans cannot always clearly tell a harmless oncocytoma from kidney cancer, doctors often need to examine a small tissue sample, or sometimes the tumor after surgery, under a microscope to confirm what it is. They also review family history, and if the pattern suggests an inherited condition, genetic counseling and genetic testing may be offered to look for a related gene change.
Stages of Familial renal oncocytoma
Familial renal oncocytoma does not have defined progression stages. That is because it is mainly a tendency to develop one or more kidney tumors over time, rather than a condition that moves through a clear step-by-step pattern. Familial renal oncocytoma is usually found with kidney imaging such as ultrasound, CT, or MRI scans, often after an incidental finding or when doctors are checking a strong family history; the early symptoms of familial renal oncocytoma are often absent. Sometimes answers come quickly, while other times it takes longer.
Outlook and prognosis
The outlook for familial renal oncocytoma is generally favorable because these tumors are usually benign and often grow slowly, so many affected people have normal life expectancy. Prognosis is best when kidney masses are carefully monitored to confirm they behave like oncocytomas and to distinguish them from renal cell carcinoma or hybrid tumors that can occur in some hereditary settings. Mortality from a pure renal oncocytoma is very low, and deaths directly attributable to these tumors are rare. The main long-term risks are related less to spread of the tumor and more to repeated tumors in both kidneys, the need for ongoing imaging, and possible loss of kidney function if multiple surgeries become necessary. People with familial renal oncocytoma usually benefit from lifelong follow-up with specialists in hereditary kidney tumors so management can balance cancer surveillance with preservation of kidney tissue.
Long-term effects
For many people, the long-term effects of familial renal oncocytoma center on how kidney tumors behave over time rather than on fast-moving illness. These growths often develop slowly and may stay limited to the kidneys, so the overall outlook is often better than with more aggressive kidney cancers. Long-term effects vary widely, especially depending on how many tumors develop, whether both kidneys are involved, and whether treatment is needed more than once.
Many living with familial renal oncocytoma develop more than one kidney tumor over the years. These may appear in one kidney or both, and new growths can arise even after earlier tumors have been treated.
A common long-term feature is that tumors often enlarge slowly rather than causing rapid decline. For many, this can mean a prolonged course with careful monitoring instead of immediate serious illness.
Kidney function may stay normal for a long time, especially when tumors are small and kidney tissue is preserved. Some may find that repeated procedures or loss of kidney tissue over time can raise the chance of chronic kidney disease.
Familial renal oncocytoma usually has a low risk of spreading to distant parts of the body. This generally makes long-term survival more favorable than in forms of kidney cancer that are more invasive.
How is it to live with Familial renal oncocytoma?
Living with familial renal oncocytoma often means living with uncertainty more than day-to-day symptoms, because many people feel well and learn about the condition through kidney imaging or family history rather than from obvious warning signs. Daily life may include regular checkups, scans, and conversations about whether a kidney growth is stable or needs treatment, which can be emotionally draining even when the tumors are benign. For families, the condition can ripple outward, raising questions about inherited risk, genetic testing, and screening for relatives, but many find that clear follow-up plans and genetics care help replace fear with a sense of control.
Treatment and drugs
Familial renal oncocytoma is usually managed with regular follow-up rather than automatic treatment, because these kidney tumors often grow slowly and may not cause day-to-day symptoms at first. Treatment often looks different for each person, but the main options are careful imaging over time, surgery to remove part of the kidney when a tumor is growing or causing problems, and sometimes treatment of more than one tumor if both kidneys are affected. When possible, doctors usually try to preserve as much kidney tissue as they can, since many living with familial renal oncocytoma may need monitoring or procedures more than once over their lifetime. There is no standard drug that makes these tumors go away, so medicines are mainly used for related issues such as pain after a procedure or blood pressure problems if they occur. If you are wondering about the early symptoms of familial renal oncocytoma, or whether a scan has changed enough to need treatment, your doctor may suggest follow-up with a kidney specialist and a genetics team.
Can you cure Familial renal oncocytoma?
No, there is no cure for familial renal oncocytoma, which is an inherited condition that causes people to develop usually noncancerous kidney tumors. Treatment does not remove the inherited tendency, but regular kidney scans and follow-up can watch for new growths, and surgery or other procedures may be used if a tumor grows, causes problems, or is hard to tell apart from kidney cancer.
Non-drug treatment
Living with Familial renal oncocytoma often means planning for regular kidney checks over time, rather than starting medicine right away. Managing this condition often centers on watching tumors closely, protecting kidney function, and deciding if or when a procedure is needed. Because these growths can be slow-growing and may resemble other kidney tumors on scans, treatment options for familial renal oncocytoma usually depend on size, growth, symptoms, and family history.
Regular imaging, such as ultrasound, CT, or MRI scans, is often the main approach when tumors are small and not causing problems. This helps your care team track growth over time and avoid unnecessary procedures when it is safe to do so.
If a tumor grows, causes symptoms, or looks uncertain on imaging, surgery to remove just the tumor may be recommended. This approach aims to treat the mass while preserving as much healthy kidney tissue as possible.
Some people may be offered heat- or cold-based treatment through a needle placed into the tumor, usually guided by imaging. This can be an option for selected small tumors, especially when avoiding a larger operation matters.
Meeting with a genetics specialist can help families understand inherited risk and who else may benefit from testing or screening. It can also make it easier to plan long-term follow-up for relatives who may be affected.
Your genes may have an impact on how drugs work for you
For most people living with familial renal oncocytoma, medicines are not the main treatment, so inherited gene changes usually do not play a big part in choosing a drug day to day. Care more often centers on watching the kidney growths over time with scans or removing a growth if it is causing problems, and treatment plans are based mostly on the size, number, and behavior of the tumors rather than on how someone’s body breaks down medicine. In the less common situation where the diagnosis is unclear or there are other kidney tumors in the family, genetic testing may help doctors sort out what kind of growth is present and whether a different treatment approach makes more sense.
Pharmacological treatments
For most people with Familial renal oncocytoma, there is no standard medicine that shrinks or removes the kidney tumor itself. Treatment for familial renal oncocytoma usually centers on monitoring and, when needed, a procedure or surgery rather than drug therapy. Medicines may still be used to ease symptoms, treat complications such as infection, or manage related problems like high blood pressure. If imaging suggests the growth may not be a simple oncocytoma, doctors may reassess and consider other treatments based on the new findings.
There is no established drug that directly treats a typical renal oncocytoma in people with Familial renal oncocytoma. In most cases, medicines are supportive rather than tumor-targeting.
Acetaminophen is often used if there is discomfort, especially after a biopsy or procedure. Nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen may help some people, but they can be risky for kidney function and are not right for everyone.
Drugs such as nitrofurantoin, trimethoprim-sulfamethoxazole, or cephalexin may be used if a urinary tract infection happens at the same time. These medicines treat infection, not the oncocytoma itself.
If kidney disease or reduced kidney function is also present, medicines such as lisinopril, losartan, or amlodipine may be prescribed to control blood pressure. Not everyone responds to the same medication in the same way.
Genetic influences
If kidney tumors have affected several relatives, it can be unsettling to wonder what that means for you and your family. Familial renal oncocytoma is an inherited condition, usually following an autosomal dominant pattern, so a parent with the gene change can pass it to each child with a 1 in 2 chance. In some families, it is linked to changes in the FLCN gene, which helps control how kidney cells grow and divide. Family history is one of the strongest clues to a genetic influence, especially when more than one relative develops renal oncocytomas or related kidney tumors. Because these tumors can run in families even when there are few or no early symptoms of familial renal oncocytoma, doctors may suggest genetic counseling and genetic testing for familial renal oncocytoma. This can help clarify risk for relatives and guide screening over time.
Is Familial renal oncocytoma genetic?
Genetics are very important in familial renal oncocytoma because it tends to run in families. In some people, inherited genetic changes raise the risk, but the exact gene change is not always found in every family.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are common across the general population. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, carrying a change tied to a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some cases, however, a single well-studied change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with familial renal oncocytoma, the biggest treatment question is often not which drug to take, but how closely the kidneys should be watched and when a procedure is really needed. Alongside medical history and scan results, genetic testing can help doctors judge whether the kidney growth fits familial renal oncocytoma alone or part of a broader inherited kidney tumor syndrome. That matters because confirmed oncocytomas are usually managed with careful monitoring or kidney-sparing surgery if they grow, cause symptoms, or are hard to tell apart from kidney cancer. Standard cancer drugs are generally not used for a confirmed oncocytoma, so the genetic result often shapes surveillance and surgical planning more than it points to a specific medicine. If testing finds an inherited syndrome, it may also change how often imaging is done and whether close relatives are offered testing, which is why genetic testing for familial renal oncocytoma can be an important part of treatment planning.
Interactions with other conditions
For many living with familial renal oncocytoma, the main concern is not day-to-day symptoms but how repeated kidney tumors, scans, and sometimes surgery can affect long-term kidney health. Another important aspect is how familial renal oncocytoma may link with other diseases. In some families, it overlaps with inherited conditions such as Birt-Hogg-Dube syndrome, which can also raise the chance of other kidney tumors and, in some people, lung cysts or collapsed lungs. This matters because doctors may need to look carefully for signs that a growth is a benign oncocytoma or a different kidney tumor that needs closer treatment. People with familial renal oncocytoma may also have more complicated care if they already have chronic kidney disease, kidney stones, or reduced kidney function, since preserving as much healthy kidney tissue as possible becomes especially important. High blood pressure can develop if kidney function is affected over time, although it is not usually a direct early symptom of familial renal oncocytoma itself. If there is a family history of mixed kidney tumors, early symptoms of familial renal oncocytoma or related kidney conditions should be reviewed with a genetics or kidney specialist so screening can be tailored to the whole picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Familial renal oncocytoma?
Other kidney growths can be mistaken for familial renal oncocytoma, especially kidney cancer such as renal cell carcinoma, including a less common type called chromophobe kidney cancer, as well as other noncancerous kidney tumors or kidney cysts. If someone has blood in the urine, side or back pain, or a mass found on a scan, doctors may also need to rule out kidney stones or a urinary tract infection, because these can cause some of the same problems.
History
For many living with familial renal oncocytoma, the condition first becomes part of life through a scan, a follow-up appointment, or a family story about relatives who had kidney growths removed years earlier. Rather than being recognized all at once, it was pieced together over time as doctors noticed that some families seemed to develop the same kind of usually noncancerous kidney tumor more than once and across generations.
Families and communities once noticed patterns that medicine could not yet fully explain. Early reports focused on the tumors themselves, which are called oncocytomas, and on how they looked under the microscope after surgery or biopsy. As imaging improved in the late 20th century, doctors began finding these kidney tumors more often, sometimes before they caused any symptoms at all. That helped show that what seemed unusual in one person could, in some families, be part of a broader inherited condition.
Over time, the picture became clearer. Specialists learned to separate familial renal oncocytoma from other kidney conditions that can also run in families, including some that raise the risk of cancer. This mattered in everyday care, because it changed how people were counseled, how often kidneys were monitored, and how carefully doctors weighed watchful waiting against surgery. For many, this can mean regular imaging and conversations about preserving as much kidney tissue as possible if treatment is needed.
In recent decades, awareness has grown as researchers compared family histories, imaging findings, and tumor features more carefully. They later identified that a genetic cause can underlie the condition, although the history of familial renal oncocytoma is really a story of observation first: families noticing patterns, doctors connecting cases, and better scans revealing tumors that might once have gone unnoticed. Knowing this background helps explain why care today often includes long-term follow-up and why the early symptoms of familial renal oncocytoma may be absent or subtle, even when the condition runs in a family.